Participants
gallstones, T2DM, thyroid abnormalities
GALLSTONES, KIDNEY REPLACEMENT
Between July 2020 and September 2020, Fifty-two (men and women) patients in the age range of years were recruited from the dialysis center of Imam Reza Hospital associated with Tabriz University of Medical Sciences in Iran. Patients who were 18 years old or older, diagnosed with T2DM, and received hemodialysis at least twice a week for the past three months were eligible for this study (each series 4 h). They also needed to be free of any acute gastrointestinal issues, thyroid abnormalities, gallstones, or a history of ginger sensitivity. After being accepted into the study, patients were ordered not to consume ginger for a month. They should not have taken fish oil supplements, steroidal and non-steroidal anti-inflammatory medicines, levothyroxine, warfarin, and antioxidant supplements. Exclusion criteria included altering kidney replacement treatment procedures (peritoneal dialysis or kidney transplantation) throughout the trial, inconsistent hemodialysis attendance, and refusal to continue supplementing. Throughout the research, a flow diagram based on the CONSORT declaration depicts the inclusion and removal of individuals (Fig. CONSORT Flow Diagram of the stud